跳至主要内容
临床试验/NCT03203668
NCT03203668Unknown不适用

Diagnostic Value of 18F-fluorocholine PET/CT Imaging in Localization of Hyperfunctioning Parathyroid Tissue in Hyperparathyroidism

University Medical Centre Ljubljana2 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2013年1月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,000
试验地点
2
主要终点
Sensitivity & Specificity

研究概览

简要总结

To assess the efficiency of 18F-fluorocholine PET/CT in localization of hyperfunctioning parathyroid tissue in hyperparathyroidism, thereby enabling minimally invasive surgical approaches with fewer complications and comparable success rates

详细描述

Primary hyperparathyroidism is a common endocrine disorder for which the diagnosis is biochemical and therapy surgical in the vast majority of cases; in secondary and tertiary hyperparathyroidism, surgical treatment is usually chosen when conservative measures fail to control the condition. The previously used surgical approach of bilateral neck exploration is being replaced by minimally invasive procedures, whose advantage is shorter duration of operation and general anesthesia, lower morbidity and fewer complications with comparable success rates.

A prerequisite for minimally invasive surgery is successful localization of the offending parathyroid tissue. Most commonly used imaging modality for this purpose is parathyroid scintigraphy with 99mTc-sestaMIBI, usually supplemented by ultrasound of the neck. Overall, parathyroid scintigraphy is a sensitive method for localization of hyperfunctioning parathyroid tissue; however, its diagnostic performance is significantly lower in patients with multiple parathyroid lesions.

In comparison to conventional nuclear medicine imaging approaches for localization of the offending parathyroid tissue, positron emission tomography with computed tomography (PET/CT) offers superior image resolution with an additional advantage of attenuation correction and co-registration of functional and anatomical information. 18F-fluorocholine is a PET tracer which is commonly used for prostate cancer imaging. In contrast to 18F-fluorodeoxyglucose (18F-FDG), it is also taken up by well-differentiated neoplasms in which 18F-FDG uptake is unreliable. The investigators hypothesize that 18F-fluorocholine might be efficiently taken up by parathyroid adenomata and/or hyperplasia.

The aim of this study is to investigate the efficiency of localization of hyperfunctioning parathyroid tissue with 18F-fluorocholine PET/CT in patients with primary hyperparathyroidism and to compare its efficiency to conventional scintigraphic imaging methods for this purpose.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age over 18 years
  • Biochemically proven hyperparathyroidism (elevated iPTH, elevated on normal Ca2+) or elevated Ca2+ and inadequately supressed iPTH

排除标准

  • Age under 18 years
  • Pregnancy
  • Clinical history of oncological, inflammatory/infectious disease of the head and neck

结局指标

主要结局

Sensitivity & Specificity

时间窗: 3 months

Ability to detect the hyperfunctioning parathyroid tissue

次要结局

  • Improvement in patient management - operating time(3 years)
  • Biochemical/clinical outcome - Ca2+ levels(1 year)
  • Biochemical/clinical outcome - iPTH levels(1 year)
  • Improvement in patient management - cost(3 years)
  • Improvement in patient management - complications of surgery(3 years)
  • Improvement in patient management - duration of hospital stay(3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Luka Lezaic MD PhD

MD PhD

University Medical Centre Ljubljana

研究点 (2)

Loading locations...

相似试验

18F-fluorocholine PET/CT Imaging in... | 临床试验